OTC : CSPCY

CSPC Pharmaceutical Group Limited

$4.09 USD

$0.05 (1.24%)

Volume
444
Average Volume
2.08K
Market Capitalization
$11.78B
P/E Ratio
20.56
Dividend Yield
3.58%
Price Target
Year High
$5.83
Year Low
$3.26
Day High
Day Low
Payout Ratio
$0.64
Current Ratio
$2.19
3333332"{? p/.m7yd f,0=

Annual earnings financials

CSPCY financial data with annual/quarterly toggle

CSPCY GAAP EPS - Annual & Quarterly

CSPCY Sales Revenue - Annual & Quarterly

CSPCY Shares Outstanding - Annual & Quarterly

Hover over bars to see exact values. Data includes up to 12 years of annual financials and up to 20 quarters of quarterly data from FMP Financial Data.

CSPCY Estimated and Actual Revenue by Quarter
CSPCY Estimated and Actual EPS by Quarter
CSPCY Analyst Forecasts — EBITDA & EBIT
Quarter Date No of Estimates Ebitda Ebit
Low High Average Low High Average
2026-12-31 1 17.51B 17.51B 17.51B 14.78B 14.78B 14.78B
2026-06-30 1 16.96B 16.96B 16.96B 14.32B 14.32B 14.32B
2026-03-31 2 13.24B 16.36B 14.8B 11.2B 13.83B 12.52B
2025-12-31 2 13.39B 15.12B 14.25B 11.3B 12.77B 12.03B
2025-09-30 3 14.66B 15.38B 14.95B 12.4B 13B 12.64B
2025-06-30 4 15.16B 17.2B 16.01B 12.79B 14.51B 13.51B
CSPCY Analyst Forecasts — Net Income & SGA Expense
Quarter Date No of Estimates NetIncome SgaExpense
Low High Average Low High Average
2026-12-31 1 - - - 25.89B 25.89B 25.89B
2026-06-30 1 - - - 25.07B 25.07B 25.07B
2026-03-31 2 - - - 19.15B 23.65B 21.4B
2025-12-31 2 - - - 19.79B 22.36B 21.07B
2025-09-30 3 - - - 21.2B 22.24B 21.62B
2025-06-30 4 - - - 22.41B 25.42B 23.66B
CSPCY Analyst Forecasts — Revenue & EPS
Quarter Date No of Revenue Estimates Revenue No of EPS Estimates EPS
Low High Average Low High Average
2026-12-31 1 72.54B 72.54B 72.54B 0 0 0 0
2026-06-30 1 70.25B 70.25B 70.25B 0 0 0 0
2026-03-31 2 55.44B 68.47B 61.96B 0 0 0 0
2025-12-31 2 55.44B 62.64B 59.04B 0 0 0 0
2025-09-30 3 61.37B 64.37B 62.58B 0 0 0 0
2025-06-30 4 62.78B 71.22B 66.3B 0 0 0 0